Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction Pemetrexed and Cisplatin Followed by Pemetrexed as Maintenance vs Carboplatin-paclitaxel and Bevacizumab Followed by Bevacizumab as Maintenance:Multicenter Randomized Phase III Study in Patients With Advanced Non-Squamous Non Small-cell Lung Cancer: a Quality of Life Oriented Phase III Trial of the GOIM

NCT01303926 is registered in ClinicalTrials.gov with Gruppo Oncologico Italia Meridionale as lead sponsor.

NCT NCT01303926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction Pemetrexed and Cisplatin Followed by Pemetrexed as Maintenance vs Carboplatin-paclitaxel and Bevacizumab Followed by Bevacizumab as Maintenance:Multicenter Randomized Phase III Study in Patients With Advanced Non-Squamous Non Small-cell Lung Cancer: a Quality of Life Oriented Phase III Trial of the GOIM
Lead sponsor
Gruppo Oncologico Italia Meridionale
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2010
Completion date
June 30, 2012
Enrollment
118 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous nonsmall cell neoplasm of lung